The central amygdala and alcohol: role of γ-aminobutyric acid, glutamate, and neuropeptides
- PMID: 23085848
- PMCID: PMC3543070
- DOI: 10.1101/cshperspect.a012195
The central amygdala and alcohol: role of γ-aminobutyric acid, glutamate, and neuropeptides
Abstract
Alcohol dependence is a chronically relapsing disorder characterized by compulsive drug seeking and drug taking, loss of control in limiting intake, and the emergence of a withdrawal syndrome in the absence of the drug. Accumulating evidence suggests an important role for synaptic transmission in the central amygdala (CeA) in mediating alcohol-related behaviors and neuroadaptative mechanisms associated with alcohol dependence. Acute alcohol facilitates γ-aminobutyric acid-ergic (GABAergic) transmission in CeA via both pre- and postsynaptic mechanisms, and chronic alcohol increases baseline GABAergic transmission. Acute alcohol inhibits glutamatergic transmission via effects at N-methyl-d-aspartate (NMDA) and AMPA receptors in CeA, whereas chronic alcohol up-regulates N-methyl-d-aspartate receptor (NMDAR)-mediated transmission. Pro- (e.g., corticotropin-releasing factor [CRF]) and anti-stress (e.g., NPY, nociceptin) neuropeptides affect alcohol- and anxiety-related behaviors, and also alter the alcohol-induced effects on CeA neurotransmission. Alcohol dependence produces plasticity in these neuropeptide systems, reflecting a recruitment of those systems during the transition to alcohol dependence.
References
-
- Aguayo LG, Peoples RW, Yeh HH, Yevenes GE 2002. GABA(A) receptors as molecular sites of ethanol action. Direct or indirect actions? Curr Top Med Chem 2: 869–885 - PubMed
-
- Aguilar-Valles A, Sanchez E, de Gortari P, Balderas I, Ramirez-Amaya V, Bermudez-Rattoni F, Joseph-Bravo P 2005. Analysis of the stress response in rats trained in the water-maze: Differential expression of corticotropin-releasing hormone, CRH-R1, glucocorticoid receptors and brain-derived neurotrophic factor in limbic regions. Neuroendocrinology 82: 306–319 - PubMed
-
- Allen YS, Roberts GW, Bloom SR, Crow TJ, Polak JM 1984. Neuropeptide Y in the stria terminalis: Evidence for an amygdalofugal projection. Brain Res 321: 357–362 - PubMed
-
- Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ 2000. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: Behavioral, endocrine and neurochemical effects in the rat. J Pharmacol Exp Ther 294: 588–597 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AA013498/AA/NIAAA NIH HHS/United States
- AA015566/AA/NIAAA NIH HHS/United States
- AA13498/AA/NIAAA NIH HHS/United States
- R01 AA017447/AA/NIAAA NIH HHS/United States
- R01 AA015566/AA/NIAAA NIH HHS/United States
- R00 AA018400/AA/NIAAA NIH HHS/United States
- K99 AA018400/AA/NIAAA NIH HHS/United States
- AA017447/AA/NIAAA NIH HHS/United States
- P50 AA006420/AA/NIAAA NIH HHS/United States
- AA06420/AA/NIAAA NIH HHS/United States
- AA016985/AA/NIAAA NIH HHS/United States
- R01 AA016985/AA/NIAAA NIH HHS/United States
- AA018400/AA/NIAAA NIH HHS/United States
- R37 AA017447/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous